Scientific environment


Health Communication Research Laboratory (HCRL)



Download 391.79 Kb.
Page5/6
Date02.02.2017
Size391.79 Kb.
#14986
1   2   3   4   5   6
Health Communication Research Laboratory (HCRL) which seeks to eliminate health disparities by increasing the reach and effectiveness of health information to low-income and minority populations. Research through the HCRL innovative and community-based programs finds new ways to reach disadvantaged populations affected most by health disparities, working to develop and deliver effective health interventions designed specifically for these populations and using technology and partnerships to connect people to health services in their community. Areas of expertise include developing tailored and general print communication programs and health and behavioral surveys, designing and conducting health communication research trials, and conducting formative research to evaluate effectiveness among target populations, including pre-testing, focus group interviews, and cognitive response testing. The HCRL physical facility includes a focus group room with an observation area. This room can accommodate 12 focus group participants, and has video, computer, Internet and teleconferencing capabilities. The adjacent observation area can accommodate six staff members who can observe the focus group unobtrusively and listen to the conversation with a monitoring system.
The Hope Center for Neurological Disorders was formed by a collaborative alliance between WUSM and Hope Happens, a St. Louis-based non-profit formerly known as ALS Hope. The Hope Center improves the lives of people living with neurological disorders, through collaborative research that aims to discover fundamental mechanisms of neurodegeneration and repair, and translate that new understanding into cures and treatments. The Hope Center brings together world-leading scientists and clinician scientists to collectively focus on mechanisms of neurodegeneration and neural repair, accelerating the translational research process through three key aims: 1) establishing state-of-the-art core resources and technical expertise, so that basic science discoveries can be rapidly tested in relevant and validated animal models; 2) providing funding for innovative disease-focused research, without the multi-year delays that can be typical for other sources of grant funds and 3) developing a research infrastructure that promotes collaboration across disciplines and institutions, trains the next generation of scientists, and speeds dissemination of information. The Hope Center offers diverse opportunities to exchange ideas and learn the latest information in translational neuroscience through noon seminars, annual retreats, and didactic coursework, including the ‘Neurobiology of Disease’ course and lectures.
The current Human Imaging Unit (HIU) will evolve into the Clinical and Translational Imaging Unit (CTIU) as described in the Hub Research Capacity Component. The HIU is a research-dedicated, comprehensive imaging center that resides in the Center for Clinical Imaging Research (CCIR), a state-of-the-art biomedical imaging facility located on the 10th floor of the West Pavilion of BJH. The CCIR provides the latest in advanced imaging technology, equipment and expertise to support basic and translational inpatient and outpatient clinical research. HIU on-site staff include nurses, imaging technologists, research coordinators, data analysts, programmers, and managers to monitor, advise, and coordinate all aspects of the imaging resources for research studies. Patient care areas via the HIU include outpatient waiting areas, an inpatient holding zone, a nurse’s station, and monitoring equipment integrated into the existing hospital system. The design includes seven private holding rooms with flexible configuration to accommodate the consent process, interviews, physical examination, or any of a variety of other procedures. Equipment includes six state-of-the-art imaging scanners in computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), combined PET/CT and ultrasound (US). Single photon emission computed tomography (SPECT) imaging cameras also can be accessed from the Center. The CCIR was one of the first three centers in North America to acquire a simultaneous acquisition whole body PET-MRI scanner (Biograph mMR, Siemens). In 2015, 90 investigators performing 197 distinct trials or studies use the CCIR. Over 70% of investigators using CCIR services are non-radiologists and often are not imagers by training. Investigators using the CCIR come from throughout WUSM as well as from Arts and Sciences (Psychology and Physics) and the School of Engineering and Applied Sciences (SEAS).
The Human Research Protection Office (HRPO) is responsible for safe and ethical conduct of research at WU, BJH, SLCH, and other sites for which HRPO is the IRB-of-record. HRPO is a group of professional staff dedicated to the 1) protection of human subjects, 2) administration and support of the Institutional Review Boards (IRBs), 3) support of researchers and the conduct of ethical research compliant with local, state, and federal requirements and 4) education of the research community.
HRPO has built an infrastructure to support the use of Central IRBs (CIRBs) that are becoming the “norm” for NIH-funded multi-center trials with one dedicated FTE for CIRB studies and expansion of other positions to provide further support. HRPO has experience with a range of IRB-reliance models from full reliance, such as NeuroNext, the National Cancer Institute CIRB, and research conducted through the Sharing Partnership for Innovative Research in Translation (SPIRiT) Consortium (a consortium of six CTSA hubs), to shared IRB reliance through participation in IRBshare and the three PCORI CDRNs in which our Hub institutions participate. All ICTS partner institutions have agreed to some degree of reliance on one another's IRBs, and HRPO is actively investigating opportunities for broader reliance among local partners. WU currently serves as the IRB of Record for 180 institutions and 195 non-WU study team members or community partners.
Within HRPO, the Human Research Protection Program (HRPP) at WU was accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP) in 2004 and re-accredited in September 2015. This process occurs every five years and affirms the institution’s capacity, compliance, and commitment to the protection of human subjects and support for the ethical conduct of research. HRPO leadership is very active in human research protections at a national level. The Associate Dean for Human Studies and Executive Chair of the Institutional Review Board was recently appointed to the Secretary’s Advisory Committee on Human Research Protections within Department of Health & Human Services. The HRPO Executive Director serves as an AAHRPP site visitor and sits on the AAHRPP Council on Accreditation.
Central to HRPO’s success is a staffing and meeting structure that supports efficient and effective reviews. HRPO supports six IRB meetings per week, which has brought current turnaround times from IRB submission to approval to an average of 46 days for new full board studies; Phase III Clinical Trials are reviewed and approved in an average of 48 calendar days (26 days with HRPO and 22 days with the PI). New expedited studies are approved, on average, in nine days. HRPO processed a total of 15,244 submissions in 2014 (12,076 Expedited, 2,136 Full Board). In an average month, the myIRB system supports 2,304 unique users who access the system 19,636 times/month and view 60,7979 different pages/month. In 2014, WU had enrolled a total of 29,192,547 research subjects (including retrospective use of data or specimens) in a total of 5,532 open studies.
HRPO provides education through the Study Initiation Program (protocol-specific visits in concert with quality assurance representatives to provide compliance guidance and best practices); on-call and office service hours through the SWAT (Staff With Answers Today) program; dedicated conferences, ongoing series, and specialized workshops extending beyond the WU community; open access publication of HRPP-oriented tools, research guidance, and media through the HRPO Digital Commons; hands-on myIRB training workshops; educational events tailored to departmental/investigator and student or team needs; flexible CITI training for WU faculty, staff and community partners; and guidance on local community-engaged research.
HRPO has detailed information regarding community engaged research to address the needs of CTSA investigators engaged in research collaborations or affiliations with community partners, and to ensure regulatory compliance for investigators and their research affiliates. The Community-Engaged Research (CEnR) program includes information on getting started (from plan, funding, assurances, and approvals, and maintains a checklist for community partnership while providing information on education and assurance requirements CBO or community partners. CITI training is not available on-line for community partner human subjects training, but options for providing approved training to community partners are available, as well as guidance for compliance with research for non-exempt human subjects through Federal Wide Assurance (FWA). IRB community members play a crucial role in the successful ethical review of research involving human subjects. In 2014, over 30 community members committed their time and expertise to fill this important role at IRB meetings.
HRPO organizes quarterly meetings of the St. Louis IRB Consortium, with partners from key institutions in the region including all ICTS partner institutions as well as MO Baptist Hospital, St. Luke’s Hospital, Mercy Hospital and SSM Healthcare, Logan College of Chiropractic, and Lindenwood University. Key conversation topics have included IRB review and submission processes, how to manage incidental findings, as well as a focus on current events in research ethics.
The High Throughput Screening Core (HTSC) specializes in small molecule screens to identify agonists/antagonist of biologically/pathologically interesting proteins, and sub- or genome-wide siRNA screens in live cell functional assays. A wide variety of siRNA (including Human Phosphatase, Kinase, Druggable Genome, and Whole Genome) and chemical compound libraries, molecular imaging platforms, and expertise with assay development and data analysis is available. The clean-room environment and an on-line humidified, CO2 incubator provide ideal conditions for performing cell-based assays, while the rail system and random access ensures the uniform treatment of every well across the entire screen.
IdeaBounce® is the flagship program of the Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship (SCIIE) and the gateway to many other opportunities, including funding. Anyone in the world can post ideas on the IdeaBounce® website and the network of creators, inventors, investors, business people, service providers, customers, mentors and others can begin to connect to transform ideas into reality, create value and bring inventions to market. IdeaBounce® is a very quick first step where bouncers receive feedback about their idea and find out what potential customers think about the concept – with follow-up through virtual connections on the website as well as in-person free, fun, fast-paced IdeaBounce® events. Events start with 2-minute ‘elevator’ pitches from pre-selected bouncers, followed by an “open mic” segment for audience members to pitch concepts that were not picked. Winners receive $100 plus an invitation to an exclusive event the following week with the judges for a private mentoring sessions. IdeaBounce® is the essential first step for all SCIIE competitions including the BearCub, Skandalaris Center Cup, Global Impact Award and Social Enterprise and Innovation Competitions.
The Induced Pluripotent Stem Cell (iPSC) Core facilitates the use of induced pluripotent stem cell technology to enable investigators to leverage our institutionally diverse patient population to study and potentially treat human disease in a novel way.

  • Skin Biopsy Processing: The iPSC Core Facility has developed an efficient protocol for the generation of dermal fibroblast cultures from skin punch biopsies to generate patient-specific fibroblast lines and their subsequent reprogramming to yield induced pluripotent stem cells.

  • iPSC Generation and Characterization: The iPSC Core Facility offers multiple reprogramming techniques for the generation of induced pluripotent stem cells from dermal fibroblast cultures, provide characterization of iPSC lines generated within the facility, as well as those obtained from external sources.

  • Training: The iPSC Core Facility offers training in various techniques related to iPSC maintenance, differentiation, and cryopreservation, as well as fibroblast reprogramming for the generation of induced pluripotent stem cells. Additionally, the facility serves as a repository for protocols related to iPSC maintenance and differentiation.

  • Cryopreservation: The iPSC Core Facility provides cryopreservation services for all dermal fibroblast and iPSCs generated within the facility.

The Innovation, Design and Engineering in Action Laboratories (IDEA LabsTM), founded in 2013 at WU, was designed to bring together students, faculty, staff, and local entrepreneurs to tackle unmet needs in healthcare delivery and clinical medicine. IDEA Labs aims to make medical entrepreneurship attainable for students; to teach engineering, medical, and business students the skills and process need to invent and implement new biomedical technologies; and to develop novel devices and software applications targeting unmet clinical needs. Through the guidance of a clinician mentor and technical advisors, student teams drawn from engineering, medicine, business and other disciplines obtain a deep understanding of clinical problems by shadowing in local clinics and academic medical centers and work collectively to devise milestones that develop design implementations on paper or through software that are then prototyped, tested and redesigned in a series of increasingly realistic models and prototypes. As impact in 2014-15, 11 startups were formed out of the program with 12 provisional patents vetted and 19 proof-of-concept prototypes developed in the annual competition. Outside investments or awards raised ~$2 Million, garnering nationwide expansion of the IDEA Labs concept through a unique collaboration with the American Medical Association to help inspire and support cutting-edge medical technology development from the next generation of young entrepreneurs studying at WU, Harvard University, Massachusetts Institute of Technology, University of Pennsylvania, and University of Minnesota.


The Institute for Health Systems Innovation (IHSI) is a joint initiative between Center for Biomedical Informatics (CBMI) faculty and BJC focused on improving healthcare through the development of a sustainable platform for population and patient-centered improvements. The IHSI was created with a $20M commitment from BJC to enhance capacity for innovation and discovery and to facilitate progress in bedside-to-community research. At the heart of IHSI are its integrated data assets that include clinical, operational, and third-party administrative and public health data. IHSI also facilitates advanced analytics to improve individual and public healthcare in innovative ways. Specifically, IHSI is dedicated to: (1) developing and maintaining the electronic infrastructure facilitating an expeditious clinical and translational research; (2) promoting the use of electronic resources maximizing the safety and quality of patient care; and (3) developing comprehensive training programs in biomedical informatics. Through resource pooling, data request processes are expedited, thus erasing the inefficiencies of prior established practices.

  • The Public Health Dashboard is a collaborative project of IHSI and the Center for Public Health Data and Training at the IPH. The Dashboard will create a portal to integrate shared public health and community relevant data obtained from a broad array of third-party administrative and public health resources across collaborating partners and link this data to internal patient data from WUSM and BJC. The Dashboard will provide baseline data gathered from the ‘For the Sake of All’ Project and will combine health data with concepts derived from Federal Research Economic Data (FRED).

  • The IHSI maintains a core faculty of investigators to support comparative effectiveness, patient-centered outcomes, healthcare research, clinical informatics, data mining and analytics, epidemiology, behavioral science, dissemination and implementation science, and quality improvements. IHSI also maintains support personnel and tools that help investigators at BJC, WU, and affiliated academic and healthcare institutions to pursue novel solutions for relevant healthcare problems. This framework facilitates rich assets for fertile analytics over the pooled data assets. Finally, IHSI supports investigator training by providing data access, analytical support, and faculty mentors. Governance is provided by a partnership between BJC and WU.

The Institute for Informatics was formed by joining the existing Center for Biomedical Informatics (CBMI) and BJC informatics within the BJC Center for Clinical Excellence (CCE) (described separately as Resources). The Institute is led by a group of active and experienced bioinformatics experts and integrates elements of Medical Informatics, Bioinformatics and Computational Sciences. It offers industry-standard, enterprise-class infrastructure and software tools to store, integrate, query, analyze, and visualize complex clinical and molecular data sets.


The Intellectual and Developmental Disability Research Center (IDDRC) partnered with SLCH to become one of a network of 15 NICHD-funded Centers of Excellence for research in mental retardation and developmental disabilities which are linked to existing CTSA programs. The IDDRC aims to implement cutting-edge innovations in science for the discovery of new higher impact interventions for individuals with developmental disabilities and incorporate vigorous interchange with scientists in other institutions, clinical providers and the local community. Currently, the IDDRC comprises over 45 active programs of research in intellectual and developmental disability conducted by its 70 participating investigators, including active research in clinical trials for new interventions.

  • The IDDRC Clinical-Translational Core promotes excellence and accelerates progress in the design and implementation of comprehensive, integrative, multidisciplinary, translational research with infants and children to enhance the prevention, diagnosis and treatment of developmental disabilities. This Core provides crucial infrastructure, professional expertise and assessment services that are essential to thoroughly characterize the phenotypes (cognitive, behavioral, social and emotional domains of development) and genotypes of children with developmental disabilities. The Core also utilizes ICTS world-class facilities for genomic research, including the Genome Technology Access Center (GTAC) for genomic sequencing and the Genomic Engineering and iPSC Center (GEiC) (described in H.1- Translational and Applied Genomics resources).

  • The IDDRC Developmental Neuroimaging Core supports high-quality basic and applied magnetic resonance (MR) imaging research relevant to understanding and preventing the causes of intellectual and developmental disabilities. This Core works closely with the ICTS Human Imaging Core (HIU) to foster translational research by enriching interdisciplinary collaboration across basic and clinical services using imaging as a research tool.

  • The Model Systems Core provides expertise in the generation of new animal and neuronal cell models capitalizing upon state-of-the-art genetic engineering techniques available through the Genomic Engineering and iPSC Center (GEiC). This core assists in the development of strategies based on prenatal therapies as well as gene and stem cell therapy and promotes a better understanding of genetic modification in disease processes in intellectual and developmental disabilities.

A series of programs developed for pediatric residents, fellows, junior faculty and practicing physicians coalesced to form the Interdisciplinary Career Development and Translational Research in Pediatrics Program to enhance and expand the clinical pediatric research opportunities available at WU and to foster career development for pediatric investigators. These programs ensure rigorous training in clinical research programs, and hands-on research experiences that take into consideration the special needs of children and families. Although there are many collaborations between investigators in pediatrics and investigators working with adults, this program provides an institution-wide mechanism to help integrate research in children into broader institutional research programs. This institutional support includes training and resources for issues related to informed consent, recruitment, ethics, vulnerable patient populations, sample size issues for rare diseases and conditions, increased participant risks, and greater difficulty performing procedures and obtaining specimens.


The Charles F. and Joanne Knight Alzheimer's Disease Research Center (Knight ADRC) in the Department of Neurology, at WUSM, is funded in part by the National Institute on Aging. The Knight ADRC facilitates research on clinical, genetic, neuropathological, neuroanatomical, biomedical, psychosocial, and neuropsychological aspects of Alzheimer's disease (AD) and related brain disorders. This center is at the forefront of a worldwide effort to uncover key causal factors in the development of AD, with a goal of developing more effective treatments and an eventual cure. The Knight ADRC is located in a WUSM-owned medical office building at 4488 Forest Park on the Medical School campus. This space is ideally suited for research participants with ample and convenient parking and full accessibility. Imaging at the Knight ADRC occurs at the Center for Clinical Imaging Research (CCIR) which houses the latest hybrid imaging technology, whole-body PET/MR imaging via the Siemens Biograph mMR scanner. This scanner combines two well-established human imaging techniques, PET and MRI. The Knight ADRC Biomarker Core is located in the new state-of-the art Barnes-Jewish-Christian Institute of Health (BJCIH) research facility at WUSM. The facility includes approximately 245,000 SF of laboratory, vivarium and support space. These laboratory spaces (~2000 SF) are constructed as an open floor plan with laboratory space for Knight ADRC-affiliated investigators. An important focus of the Knight ADRC is the differentiation of mild dementia of the Alzheimer type (DAT) from normal aging, through the African American Outreach Satellite. The activities of the Satellite are designed to support this focus by ensuring that the participant pool for the Knight ADRC is appropriately diverse. The Satellite seeks to identify and resolve barriers to research participation for African Americans, particularly those in the mildest stages of DAT. In addition, the Satellite works to provide new information about attitudes, perceptions, and beliefs regarding specific research activities (clinical trials, blood collection for genetic analysis, neuroimaging studies, lumbar puncture for collection of cerebrospinal fluid, autopsy) to enhance understanding and promote committed research participation.
Mallinckrodt Institute of Radiology (MIR): The MIR provides a full range of diagnostic radiology procedures, including conventional radiography, ultrasonography, computed tomography, and magnetic resonance imaging. In addition, MIR provides nuclear medicine examinations (including positron emission tomography) and interventional radiology procedures. The MIR faculty consists of 73 full-time academic physicians who are board certified in radiology and/or nuclear medicine, as well as 45 PhD scientists, including physicists, chemists, and computer scientists. MIR is organized into three divisions: Diagnostic Radiology, Nuclear Medicine, and Radiological Sciences.
The Mallinckrodt Institute of Radiology (MIR) provides all diagnostic and therapeutic radiology services for the WUSM and BJH, and supplies Centralized Regulatory Services (CRS) to support ICTS investigators seeking to conduct early-phase, FDA-monitored studies. The CRS is a central core of unique Radiology research professionals with years of regulatory experience in pre-clinical and clinical studies of a variety of disciplines. The goal is to help facilitate continuity and efficiency of regulatory submissions in order to improve study timelines from initiation to final approval, accelerate study start-up, and reduce PI time spent on non-revenue generating activities. MIR’s CRS can provide comprehensive support for regulatory requirements including FDA submissions for Sponsor-Investigator Investigational New Drug (IND) applications including first-in-man exploratory IND applications and Institutional Review Board (IRB) submissions, as well as other university regulatory governing bodies, including the Radioactive Drug Research Committee (RDRC).
Approximately 618,000 diagnostic imaging examinations, 39,000 nuclear medicine studies, and 31,000 interventional radiology procedures are performed annually at MIR’s facilities at BJH north and south campuses, SLCH, Barnes-Jewish West County Hospital and Barnes-Jewish St. Peters HospitalCenter for High Performance Computing (CHPC): The CHPC provides the resources and expertise to tackle any computationally-intense research project undertaken by the WUSM research community. Located in the McDonnell Genome Institute's 16,000 SF Tier 4 data center at the Medical School Campus, the CHPC offers users access to ~1,800 computing cores, 10TB of memory and 19TFLOP/s of computing power as well as high-speed networking, bulk storage and technical support. Service is free to members of contributing departments at the Medical School and Danforth Campuses. Since inception in 2010, over 3.8 million research jobs have been processed, specifically covering ~20 million processors' hours of work. This would take a single PC-core approximately 2,300 years to accomplish.

  • Central Neuroimaging Data Archive (CNDA): The CNDA is a resource for managing study data collected by the WUSM neuroimaging community. It includes a secure database, automated pipelines for processing managed data, and tools for exploring and accessing the data. The archive currently stores over 25,000 individual scans from all major modalities. It also manages an extensible set of non-imaging data, including neuropsychological, clinical, biomarker, genetic, and behavioral data. The CNDA is hosted by the Neuroinformatics Research Group (NRG) and is the site of the NRG flagship installation of the Extensible Neuroimaging Archive Toolkit or XNAT, an open-source software package for managing neuroimaging and related data. Researchers who use the CNDA also have the capability to create their own custom pipelines to handle specific image-processing tasks central to their research. As the most heavily used instance of XNAT, the CNDA’s user group provides invaluable feedback toward the ongoing development and improvement of the XNAT system.

  • Clinical Research Lab (CRL): The CRL, described previously under Regulatory Knowledge and Support, provides coordination services to support the basic and clinical research of WU investigators needing advanced imaging and information technology systems. The CRL provides training, design, execution, and analysis of imaging to support basic and translational science.

  • Cyclotron Facility: The Cyclotron Facility provides PET isotopes, radiochemicals, radiotracers, and radiopharmaceuticals to the research and medical communities for use in research and clinical practice. The Cyclotron Facility underwent a $12 million expansion, completed in August of 2014. This expansion added a fourth cyclotron to the facility (TR 19/9 – the highest performing radioisotope production cyclotron available) along with space for an equivalent cyclotron for future expansion, an ISO Class 7 Good manufacturing practice (GMP) production area, GMP quality control lab, GMP reagent lab, two solid target processing labs and shipping and receiving areas to support operations. The goal with this expansion was to develop a facility to generate and support the production of first-in-human and other novel radiotracers that could undergo phase 0, phase I and subsequent phase assessment in the HIU. The first such radiotracer – a WU developed receptor targeted nanoparticle radiotracer for atherosclerosis assessment – received FDA IND approval for research with assistance from the Cyclotron Facility infrastructure and then completed phase 0 testing in the HIU in 2015. Phase I assessment in patients with carotid artery disease began this past Fall. An updated, state-of-the art shielded pneumatic tube system was installed 2014 which allows transport of radiotracers from the Cyclotron Facility to the HIU in under 27 seconds.

  • MRI Facility: This imaging facility has an 1 MRI scanner dedicated exclusively to both clinical and non-clinical research involving outpatients and healthy control subjects. Researchers with MR certified personnel can operate the scanner or an MRI Technologist is available upon request. The facility supports both human and animal research with a strong emphasis on brain imaging

  • Neuroimaging Informatics Analysis Center (NIAC): The NIAC provides data management, processing and analysis, computing, and consulting to WUSM’s neuroimaging community. Our services enable the university's researchers to study virtually every aspect of the brain in normal and diseased states, including Alzheimer's Diseases, autism, stroke, depression, traumatic brain injury, schizophrenia and many other disorders.

  • Pre-Clinical PET/CT Imaging Facility: This facility is a core within the Department of Radiology for small and large animal PET and CT imaging studies. Animal models of disease such as in mice and rats have become an indispensable part of research for the development of new imaging probes and validation of novel therapy drugs. To support this research endeavor, the facility provides investigators with the tools and expertise to gather reliable and reproducible data. Located in proximity of the Cyclotron Facility, the Pre-Clinical PET/CT Imaging Facility has easy access to wide array or radio-pharmaceuticals on demand to maximize close collaboration. The services include PET, CT, and Cerenkov Imaging in small animals as well as radiopharmaceutical biodistribution studies in addition to various animal surgical procedures. This facility constitutes the Nuclear Medicine Imaging component of the BJH and WU SCC Small Animal Cancer Imaging Core.

  • Small-Animal Magnetic Resonance Facility located within the Biomedical Magnetic Resonance Laboratory (BMRL) has state-of-the-art facilities and equipment found at few laboratories in the world. The Facility houses 4.7-T and 11.74-T MRI systems with magnetic field strengths substantially higher than generally encountered in clinical systems. These offer improved spatial or temporal resolution for imaging and improved accuracy of resonance amplitude and frequency estimates for spectroscopy. Peripheral resources include animal holding and procedure rooms, a wet chemistry lab, an electronics lab and a climate-controlled room holding computer server and data archival devices. Experienced BMRL scientists provide a full range of research services, from initial planning and implementation to data collection and analysis. The Small-Animal Magnetic Resonance Facility is a cost-effective way to include preclinical MRI and spectroscopy in research.

The March of Dimes Prematurity Research Center (MOD Center) was established in 2014 to improve the health of babies by preventing birth defects, premature birth, and infant mortality specifically by addressing the crisis of preterm birth. In partnership with SLCH, the MOD Center became the third prematurity research center supported by the March of Dimes aimed exclusively at finding the unknown causes of preterm birth. Causes of preterm birth likely involve highly interactive biologic and environmental factors that will not be uncovered by singular studies from isolated disciplines. The MOD Center examines 1) cervical remodeling; 2) 3-dimensional electrophysiology of the uterus; and 3) chronodisruption as a risk for preterm birth, and is establishing a cohort of 1,000 women to be followed through pregnancy with individual level data collected about demographic, environmental, physiology, genetic and outcomes (the delivery and the offspring). Since this cohort will be derived from the women presenting to the BJH Obstetrics Service, it will be enriched for underrepresented minorities and those of lower SES, and it is anticipated that about one-third will deliver prematurely. In addition, the outcomes of these pregnancies (that is, the offspring) will create a new inception cohort of well-characterized infants who can be followed to explore developmental and disease outcomes.


As a world leader in the fast-paced, constantly changing field of genomics, the McDonnell Genome Institute (MGI) is one of only three NIH funded large-scale sequencing centers in the United States. The MGI brings strengths and efficiencies to the CTSA research community and has the capacity to perform large MCTs. Since its inception in 1993, the institute has played a vital role in the field of genome sequencing, receiving over $800 million in funding. The MGI began as a key player in the HGP – an international effort to decode our genetic blueprint – ultimately contributing 25 percent of the finished project.

  • The MGI also has the potential to affect populations around the world by studying variation in our genomes, in the communities of microbes living in and around us and by decoding the genomes of many other important organisms and food sources. The mission is to improve the human condition by producing, studying and interpreting high-quality genome-based data that drive biological discoveries ranging from the bench to the hospital bedside. While biomedical research areas such as cancer, other chronic and infectious diseases and human genetics are at the heart of activities, the MGI was also part of a $150 million NIH Roadmap project to sequence and understand the human microbiome – the complement of microbes that colonize the human body.

  • The MGI is located at 4444 Forest Park Ave., on the northeast corner of the Medical School Campus. Currently, MGI occupies 56,660 square feet of space for laboratory and administrative personnel in purpose-designed space to accommodate production sequencing activities and includes specialized equipment to maintain strict power and temperature requirements. A 900 square-foot technology development laboratory is available for testing prototype equipment and developing new hardware and biochemistry. A large cold room and walk-in freezer are available on the floor.

  • The CLIA licensed environment (CLE) occupies 2,412 SF of space. The data center is housed in a distinct 15,600 sq. ft. state-of-the-art facility that contains fully redundant power and cooling systems capable of housing over 100 racks of high-density network, server and storage systems in its 3,100 SF raised floor computer room. The computational cluster has 517 servers, 5,926 cores, and 1.1 petabytes of RAM, and runs on average 2.5 million individual computational jobs per month equal to 131 years wall clock time. A 1 Gigabit external network link protected by a modern firewall and a 10 Gigabit link on the Internet 2 research network, which is protected by a central WU router with a whitelist of collaborating institutions such as CGHub and NCBI sequence data repositories. To insure continuity of services in the case of a disaster, defined service level agreements and nightly backups of critical data, which are stored monthly are maintained and retained for one year at an off-site location.

The ICTS Metabolomics Core is a CLIA-certified laboratory providing targeted metabolomics analysis, support for pharmacokinetics (PK) and Pharmacodynamics (PD) studies, bioanalytical method development and validation, and pre-clinical and clinical sample analysis. The Metabolomics Core Facility was established by the Diabetic Cardiovascular Disease Center (DCDC) and the Center for Women's Infectious Disease Research (cWIDR), and is a resource available through the ICTS JIT voucher program. The Core Facility is a 1,500 SF mass spectrometry-based resource in the 10th floor of the BJCIH building that has been designed for analysis of small molecule metabolites in blood or body fluids to identify biomarkers for detection and treatment of human diseases.


The Musculoskeletal Research Center (MRS), formed in 2012 by Division of Bone and Mineral Diseases with the Departments of Orthopaedic Surgery and Internal Medicine, aims to enhance the productivity of established musculoskeletal scientists, to support young investigators in the field of musculoskeletal research and clinical care, and to facilitate collaboration between established skeletal scientists and those bringing non-traditional questions and strategies to the discipline. Just-In-Time funding is available to support investigators in obtaining data for developing a clinical/translational proposal for extramural submission or to develop new research directions. The MRS offers a small grants program, with funds available to support team building and grant planning activities for Teams in Translational Musculoskeletal Research. An active seminar and journal club series continues throughout the year, including a summer educational series exploring topics in 2016 such as bioinformatics in high throughput sequencing, epigenetic analyses, and the design of complex animal experiments. A Skeletal Biology and Pathophysiology Mini-Course is offered weekly along with a half-day symposium featuring poster sessions, latest laboratory updates and a featured speaker.
The MU Center for Health Policy (MU-CHP) supports health policy and collaborative health equity work at the communities levels through health systems, academia, advocacy groups, community based organizations, public health officials and policymakers. In partnership with the MU Office of Social and Economic Data Analysis (OSEDA) and MO HealthNet, Missouri’s Medicaid Program, CHP houses the MO HealthNet Data Project, which facilitates the utilization of Medicaid claims data by researchers and policy analysts concerned with population health, evaluation, quality improvement and cost savings across health care systems. Datasets, technical assistance and data analysis are available to data requesters through an established process with MO HealthNet.
The MU Coulter Translational Partnership Program (MU-Coulter TPP) was initiated in 2012 as a joint initiative between the University of Missouri-Columbia and the Wallace H. Coulter Foundation, a Charitable Remainder Trust established to provide leading scientific and medical societies the resources necessary to develop distinctive educational programs designed to improve the quality of care in resource-limited areas. The MU-TPP is a university-based translational research grant program providing seed (~$25,000) or full bridge (~$100,000) funding designed to establish a business-like process to accelerate academic innovations to the marketplace. Since program inception, 18 projects have received funding support through an annual vetting process that includes staged project development monitored by a program oversight committee with membership drawn from biomedical engineering faculty, clinical specialists, Office of Technology Management representatives, venture capitalists, entrepreneurs and industry representatives. The MU-TPP MU is in elite company as one of just 16 schools to host a Coulter program, which fosters groundbreaking, collaborative research with practical business plans to turn ideas into tangible products.
The MU Informatics Institute (MUII) is a partnership with the MU SOM and other stakeholders such as the SSON and the MU-CVM. The three major emphasis areas include Bioinformatics (sequence analysis, structural biology, plant phenotypes, animal sciences), Health Informatics (EMR/HER, Neuroscience and imaging informatics, text mining, nursing informatics, mHealth) and Geospatial Informatics (epidemiology, public health, intelligence, agriculture, ecology and environmental studies).

  • Several major research initiatives that cover large-scaled biomedical data analysis in ‘big data’ formats, complex morphoproteomics and applying information to individualized cased through ‘precision medicine’ approaches, and One Health partnerships aimed at minimal animal and clinical data to address complex research questions are supported institutionally. The interdisciplinary MS degree in Data Science and Analytics is offered through MU, building on 19 credits in core competencies in database and analytics, data and information ethics and big data security, data mining and information retrieval through nine credits in emphasis areas such as biotechnology, high performance computing, socio-technical data analytics and culminating in a capstone experience on big data analytics (6 credits). MUII supports training programs that cover i2b2 introductory material, various REDCap resources, HealthFacts (providing HIPAA-compliant de-identified patient data from 90 institutions including MU Healthcare) analytics and weekly informatics walk-in clinics.

  • The MUII has grown since its inception in 2000, and currently enrolls 34 doctoral students training under 43 core faculty members from 17 departments and 8 colleges. The Institute offers informatics students the chance to participate in campus-wide labs and research centers. MUII is managed by the Interdisciplinary Degree Programs Office under the MU provost to ensure its autonomy from individual colleges and schools. MUII is a highly successful interdisciplinary degree programs, graduating 19 PhDs to date with a 100% placement rate. In addition to ranked faculty positions (UNC-Chapel Hill, Mississippi State University, University of Minnesota, University of Nebraska-Omaha, and MU) and post-doctoral appointments (Virginia Tech), MUII graduates have become senior scientists at federal research labs (Sandia National Lab), data scientists in industry (Microsoft), and founders of startups across the country.

ICTS investigators have access to the University of Missouri Research Data Center (MU-RDC), a joint project between the US Census Bureau and the University of Missouri. The MU RDC is a satellite branch of the Kansas City RDC that is located at the Federal Reserve Bank of Kansas City. The facility, located in Ellis Library at the MU Campus, provides a secure environment where researchers with approved projects can access restricted-use datasets. The MU RDC gives researchers access to hundreds of federal datasets that will support research in economics, sociology, and public health. Generally, there are four categories of data on which qualified researchers may perform statistical analysis inside the secure MU RDC: demographic data, economic data, linked business and household data through the Longitudinal Employer-Household Dynamics (LEHD) data, and health (non-census) data.


The Nutrition and Obesity Research Center (NORC) works to enhance understanding of the basic and clinical aspects of nutrition in the prevention, etiology, pathophysiology and therapy of nutrition-related diseases. Since its inception in 1999, the NORC has served as a nucleus for the growth and development of nutrition and obesity research through four core facilities: Adipocyte Biology Molecular Nutrition Core (ABMN), Animal Model Research Core (AMR), Biomolecular Analysis Core (BMA), and Clinical Science Research Core (CSR). Overall, the NORC aims to 1) stimulate new and innovative nutrition and obesity research and to support collaborative research among investigators from different disciplines; 2) attract new investigators to the field of nutrition and obesity and enhance their development as independent and creative investigators through access to specialized hands-on training, core laboratory resources, shared facilities, and training and educational programs; 3) improve the training and education of students, house staff, postdoctoral research fellows, physician faculty, and allied health personnel in clinical nutrition, clinical obesity and nutrition/obesity research; 4) improve nutritional aspects of patient care by enhancing clinical nutrition services and by improving physician and health care provider nutrition knowledge; and 5) coordinate and promote community education and research to promote health and reduce obesity in the greater St. Louis Metropolitan area.
The Office of Technology Management (OTM) assists members of WU in the management of a wide variety of intellectual properties arising from research programs throughout the university, ranging from patents, copyrights, know-how, and proprietary materials to assisting faculty with consulting agreements. The current portfolio contains active and pending patents in areas of technology ranging from gene therapies to magnetics. In 2015, OTM supported 4 start-up companies, 149 invention disclosures and 146 US patents/PCT, as well as >750 Materials Transfer Agreements (690 Academic; 62 Industrial). Using OTM resources, nearly $31M licensing revenues were realized in 2015, representing a 3.4-fold growth from the previous year.
OTM is located in first floor office space (~20,000 SF) in 4240 Duncan, the Phase II project of the growing CORTEX Innovation District. The Quick Start License is a new initiative provided through OTM to foster the formation of new startup companies based on new WU technologies via a simplified process (no upfront fees or performance payments) that will allow faculty to focus on the development and commercialization of products, streamline the contract negotiation process, and enhance the attraction to potential investors. The Women in Innovation and Entrepreneurship (WIE) initiative, sponsored by OTM, seeks to increase gender diversity by navigating female faculty through the WU invention and commercialization process by providing educational seminars, workshops, and a network of internal and external individuals involved in commercialization. 
A range of educational and training opportunities are offered through the OTM including:

  • FastTrac® TechVentures™ is a business planning and development course designed specifically for technology-based entrepreneurs by the Kauffman Foundation. This course is offered periodically through the OTM in conjunction with the Small Business Development Center of Missouri. Outside Guest Lecturers include: Intellectual Property Professionals, Attorneys, Venture Capitalists, Angel Investors, Technology Transfer Specialists, SBIR/STTR Experts, Marketing Professionals, Public Relations, Human Resource Professionals, and WU Faculty Founders.

  • Faculty Seminar Series, The OTM offers a series of seminars targeted specifically to faculty interests. Each seminar pairs an external industry expert with an experienced member of the WU faculty to explore topics in intellectual property, industry relationship building, commercialization, and other subject matter that relate to technology transfer. 

  • Technology Transfer Workshop, The OTM has developed a workshop to provide WU community members with an introduction to technology transfer and an understanding of how technology transfer intersects various efforts in intellectual property (IP) and commercialization within WU. The workshop is also designed to provide concrete examples and best practices in technology transfer as it directly relates to laboratory researchers in their everyday roles. Participants are exposed to intellectual property, technology transfer and commercialization topics through sessions and case studies taught by OTM and individuals from the greater St. Louis commercialization community. 

  • OTM Trainee Program. This unique trainee program exposes the individual to a broad range of technology transfer related activities, allowing the acquisition of skills and experience in the commercial development of research discoveries. This is a three phase training program involving: I) trainee shadowing a Business Development Director (BDD), 2) project-driven trainee and project oversight by BDD, and 3) final skills demonstration.

The Office of Training Grants, co-located with the Clinical Research Training Center (CRTC) Administrative Core, directly supports the ICTS Council of NIH-funded Training Programs designed to develop strategies to optimize recruitment of the most talented trainees, create strategies to improve recruitment of women and under-represented minorities as trainees/scholars, optimize joint approaches to meet curricular requirements that span various training programs. This forum provides an annual opportunity to share best practices, including educational resources/materials, curriculum content, evaluation and competency materials, and methods to foster successful long-term tracking of trainees and mentors; and brainstorm on strategies to smooth the transition from trainee to junior faculty status. The OTG hosts Mock Study Sections twice a year, which are designed to simulate an actual NIH study section. In this process, NIH clinical and translational R, K, and F series grant applications will be reviewed, critiqued, and scored by three internal faculty members as well as other study section members and the feedback will be distributed to applicants prior to the NIH grant deadline. The OTG has developed a Grants Library to serve as a centralized resource for grant writers and investigators at various career stages.


Activities related to translational workforce development are supported through the WU Office of the Vice Chancellor for Research (OVCR), which regularly collates information on educational opportunities , the ICTS CRTC, and various student-led or center-supported programs. Many clinical research education and training modules provided through the OVCR can be taken on-line and are supported through the Learn-At-Work Program.


Summary of Translational Workforce Development Resources through OVCR

Program

Target Group(s)

Description

Admin

Clin. Research Coord.

PI or researcher




Clinical Research Education and Training

Billing Matrix Training

X







Billing Matrix system houses information on clinical trials and the participants that are enrolled in them to help WU bill correctly for clinical items and services provided in the context of a clinical research project. Individuals must complete an online training session to obtain access to the Billing Matrix. [On-line]

Research Career Development Program

X

X




The Research Career Development Program is designed to offer training and continuing education opportunities for clinical and behavioral research professionals. These are monthly sessions which offer a series of modules and individual sections based on research related topics. [Seminar recorded with on-line access]

CITI Human Subjects Training [Online Modules]







X

The CITI modules are designed around the type of research being conducted (biomedical or social-behavioral) and the research setting. These modules will meet the requirements of the Human Research Education Policy​. This policy defines educational requirements for anyone undertaking human research at Washington University.

ACRP Good Clinical Practice Certification




X

X

The Good Clinical Practice Certification is designed to give the researcher a basic understanding of the regulations and requirements for research using investigational (not approved by FDA) drugs or devices. This Certification is valid for three years, and can be earned by successfully completing a Test-Out Challenge or by taking an online course with content specific for PIs and CRCs.

HRPO Educational Programs

X

X

X

HRPO offers many programs related to human subjects research, such as New Submitter's Orientation, the HRPO Ethics Series, and Question and Answer Sessions on various human research topics. Visit the HRPO Education website for more information.

Necessary Elements in the Fundamentals of Human Subjects Research

X

X

X

Three-day introductory course to the conduct of human subjects research at WU which delivers an overview of research ethics and the research process from study origination through project close-out. Visit the Necessary Elements webpage for more information.

Responsible Conduct of Research (RCR) Education and Training

Identified RCR Education




X

X

OVCR offers listings of educational opportunities for researchers interested in learning more about ethics and responsible conduct in research. Includes coursework, calendars to seminar programming (faculty, post-docs, graduate students) and on-line training videos to educate clinical and social researchers on the importance of appropriately protecting research subjects and avoiding research misconduct.

Program for Ethical and Responsible Conduct in Science and Scholarship (PERCSS)




X

X

Washington University provides education in ethics and responsible conduct in research via PERCSS, which provides WU-specific online learning modules and regular face-to-face ethics workshops. Web-based learning modules are:

 Introduction to Ethical and Responsible Research

 Authorship and Publication

 Collaborative Research

Conflict of Interest

 Data Ownership, Acquisition, Sharing, and Management

 Mentor-Trainee Relationships

 Peer Review

 Research Integrity


The Patient-Oriented Research Unit (PORU) is the academic and administrative infrastructure for patient- oriented investigators in the Department of Pediatrics. The PORU has dedicated space located in 22,000 square feet on the 10th floor of the Northwest Tower. This area comprises office space for 22 investigators and additional workspaces for support and research staff. There are locked NIH computer rooms and storerooms for study medications and supplies, conference rooms, and work areas with copy machine/FAX/printers. The PORU administrative group includes administrative and financial support as well as a regulatory (IRB) specialist who assist clinical investigators in the Department. In FY 2015, the PORU staff assisted 87 investigators with projects totaling $17,764,009 (direct costs).


The ICTS Proteomics and Mass Spectrometry Program (PMSP) offers next generation mass spectrometry and data analysis tools for global and targeted protein quantification in biological fluids and tissues. Consultation on experimental design, selection of analytical platforms and sample preparation are provided. PMSP offers integrated proteomic workflows for discovery and verification of protein targets in biological fluids and tissues. Procurement and sample preparation methods; access to software tools for global and targeted quantitative proteomics; support for customized database construction for high-specificity analysis of post-translational modifications; and a centralized data structure for access, storage, backup and retrieval of raw and processed MS data are provided through the proteomics program core. The PMSP laboratory includes instrumentation for automated, microscale preparation of biological fluids and tissue, supported by three robotic liquid handling devices for the solid phase extraction of peptides, the enrichment of proteins using immobilized tips and the processing of multi-well plates for ELISA assays. This facility, an NCI-designated Proteome Characterization Center, is housed in a 3,500 SF customized proteomics laboratory on the 7th floor of the Southwest Tower at the Medical School Campus.
The Public Health Data and Training Center at the IPH aims to put public health data into action by promoting its effective use in research, practice and policy and provides additional informatics resources. The key strategies are to: 1) Build the capacity of students, faculty and community partners to use and interpret data; 2) Stimulate transdisciplinary collaboration to address specific public health issues; 3) Provide centralized access to diverse public health datasets; 4) Attract and train the next generation of public health researchers; and 5) Create opportunities to share important public health information with the community. The Center offers 90-minute, tailored “crash course data workshops” which covers a range of topics, including how to open and use the software, data import/export and management, programming syntax, graphs, and basic statistics for training and professional development. A SAS® users-group was created in 2015 as a forum to network and share knowledge.
Leveraged community and collaboration resources at WU are available through the Program for the Elimination of Cancer Disparities (PECaD) within the SCC, emphasizing prevention and control. The PECaD program aims to create a national model for eliminating disparities in cancer through community-based partnerships. PECaD encompasses SCC efforts to address pervasive issues of disparities of cancer diagnosis, treatment, prevention and control and education. PECaD works through community partnerships, research, and education to foster healthy communities and break down barriers to quality cancer care. The PECaD Clinical Trials Outreach Program has established a successful multi-year program for increasing participation in cancer trials that has extended the catchment area to seven Missouri and five Illinois counties over its twelve years of operation.
The Recruitment Enhancement Core (REC), is a portion of the Recruitment Innovation Unit (RIU), helping ICTS investigators establish and meet study recruitment targets (including adequate participation by women and underrepresented minorities) while ensuring regulatory compliance and the highest ethical standards in participant recruitment. The REC is comprised of dedicated recruitment specialists for developing and implementing participant recruitment plans across all studies. The REC supports eMHR searches and research data repository queries (consistent with IRB and HIPAA rules), and provides assistance with creating targeted, comprehensive approaches to participant recruitment (to include creative solutions to existing and potential recruitment challenges), which will maximize recruitment efforts for clinical trials. The REC augments these activities with advertising assistance, by print or electronic media, both in development of materials and strategic placement. The REC creates a communication bridge between all members of the study team to optimize each entities value in the process. The proof of concept pilot for these recruitment related strategies has yielded a 2 fold increase in enrollment accrual. REC provides access to: 1) the Research Participant Registry (RPR) database, 2) the REACH (Research Engagement to Advance Community Health - the recruitment and retention arm of the CCHPR), and 3) the Emergency Care Research Core (ECRC) which provides consultation and recruitment services for studies involving clinical research in acute illness and injury. Each of these approaches can be used to enhance recruitment by passing a steady stream of qualified participants to the investigator and study coordination team.

  1. The Research Participant Registry (RPR) database, powered by the Volunteer for Health program, provides individuals the opportunity to participate in clinical studies and play a vital role in improving health care. The RPR helps researchers find people who are interested in any of the more than 1000 WUSM clinical studies begin every year to evaluate new experimental therapies or devices and who meet study qualifications. The RPR database, holds information on over 15,000 potential participants and can be queried by study inclusion and exclusion criterion. People who are healthy and those who have medical conditions are needed, from every ethnic and age group. The RPR provides a conduit to connect individuals with studies at other institutions who partner with WUSM in clinical research. Research participants may benefit in many ways, such as making a difference in future medical care, receiving experimental drugs or devices not widely available, receiving compensation for time and effort, receiving research related medical care at no cost, ultimately taking a more active role in their own health care.

  2. REACH aims to increase research understanding and participation among underrepresented populations in order to make research more representative. REACH Community Health Workers engage with community members at locations throughout the St. Louis region, including grocery stores, libraries, employment agencies, health fairs, and food pantries. Services provided for investigators include:

  • Community flyer distribution and engagement to facilitate participation screening

  • Database targeted recruitment based on study inclusion/exclusion criteria

  • Community pre-screening recruitment from the field

  • Education regarding benefits of participation in clinical research by debunking common myths and misconceptions, and helping community members become more comfortable with the research process

REACH also provides active services for community members and organizations, by:

  • Maintaining an active presence in the community at engagement sites on a monthly basis

  • Extending engagement sites to provide on-going or single event support for underrepresented populations in research

  • Presenting to organizations regarding REACH services and/or the research process to staff or community members.

  1. The Emergency Care Research Core (ECRC) provides a mechanism to conduct research in adult populations under acute illness and injury conditions by providing consultation for study design and access to subjects based on study inclusion/exclusion criteria. The Charles F. Knight Emergency and Trauma Center is a Level 1 trauma center that handles 95.600 adult and approximately 50,000 pediatric ED visits annually. The ECRC fosters interdisciplinary collaboration for research focused on emergency care. Currently the ECRC has 27 primary investigators using some aspect of ECRC resources ranging from IT resources including case review to full ECRC coordinator screening and enrollment of patients. Almost 50% of these primary investigators have primary appointments outside the Division of Emergency Medicine, including cardiology, urology, pulmonary, hematology, neurosurgery, and physical therapy. Computer Assisted Screening and Enrollment in the Emergency Department (CASE-ED) is a proprietary program developed and maintained by Emergency Medicine to aid in automated, comprehensive screening of potential subjects for the purpose of patient-oriented clinical research in the BJH ED. The CASE-ED database receives all information entered into the electronic medical record of ED patients and updates every 15 minutes. The ECRC provides RN research coordinators who are experienced with the ED environment and electronic medical record and can work with research teams to provide consent and enrollment services such as specimen collection, ECG, vital signs, assessments, or interventions as necessary for the study in the ED.

The Regulatory Support Center (RSC), supported jointly by the Center for Clinical Studies (CCS) and the ICTS, which coordinates activities for Regulatory Knowledge and Support (RKS). which facilitates clinical research of the highest quality – supporting the effective evaluation of pharmaceuticals, medical devices, and treatment outcomes – by providing the research community with administrative and clinical research services that move trials efficiently from initial proposal through study close-out. Through the RSC, the CCS supports budget development, negotiation, and feasibility assessment for clinical research studies supported by federal/foundation grants and industry contracts, including strong support for investigator-initiated studies. The RSC provides ICTS investigators with guidance and assistance with protocol development, IRB applications, support for FDA IND/IDE requests, developing clinical trial budgets, expert study coordination, dedicated research space and quality improvement initiatives while providing recruitment support services that establish and meet study targets (including adequate participation by women and underrepresented minorities). Three core services span the regulatory process to facilitate regulatory compliance and operational best practices:


1   2   3   4   5   6




The database is protected by copyright ©ininet.org 2024
send message

    Main page